MODY 3
MODY 3 is a form of Maturity onset diabetes of the young (MODY), which is a group of inherited forms of diabetes mellitus. It is caused by mutations in the HNF1A gene.
Overview[edit | edit source]
MODY 3 is the most common form of MODY. It is characterized by an onset usually before the age of 25, a primary defect in insulin secretion and a strong inheritance pattern. The disease is caused by mutations in the HNF1A gene, which encodes a transcription factor that regulates the expression of several liver-specific genes.
Symptoms[edit | edit source]
The symptoms of MODY 3 are similar to those of other forms of diabetes, including frequent urination, excessive thirst, fatigue, blurred vision, and weight loss. However, MODY 3 often goes undiagnosed because the symptoms are mild or absent.
Diagnosis[edit | edit source]
The diagnosis of MODY 3 is based on clinical features and genetic testing. The presence of diabetes in multiple generations, the onset of diabetes at a young age, and the absence of obesity or other risk factors for type 2 diabetes suggest the diagnosis of MODY 3.
Treatment[edit | edit source]
The treatment of MODY 3 involves lifestyle modifications and medication. Patients with MODY 3 often respond well to low doses of sulfonylureas, which stimulate the release of insulin from the pancreas.
Prognosis[edit | edit source]
The prognosis of MODY 3 is generally good, but patients are at risk for long-term complications of diabetes, including heart disease, kidney disease, and eye disease.
See also[edit | edit source]
References[edit | edit source]
MODY 3 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Admin, Prab R. Tumpati, MD